Filtered By:
Infectious Disease: Pandemics

This page shows you your search results in order of relevance.

Order by Relevance | Date

Total 1816 results found since Jan 2013.

High anxiety and health-related quality-of-life in families with children with food allergy during COVID-19.
CONCLUSION: Mothers with food allergic children reported high anxiety and poor HRQL. Yet, qualitatively, day-to-day food allergy management was better during the pandemic. PMID: 32950685 [PubMed - as supplied by publisher]
Source: Annals of Allergy, Asthma and Immunology - September 16, 2020 Category: Allergy & Immunology Authors: Protudjer JLP, Golding M, Salisbury MR, Abrams EM, Roos LE Tags: Ann Allergy Asthma Immunol Source Type: research

Most Care at Allergy Clinics Could Be Postponed During COVID-19 Most Care at Allergy Clinics Could Be Postponed During COVID-19
Most allergy and immunology care could be postponed or handled virtually during the COVID-19 pandemic, according to consensus-based recommendations.Reuters Health Information
Source: Medscape Allergy Headlines - April 3, 2020 Category: Allergy & Immunology Tags: Allergy & Clinical Immunology News Source Type: news

Harsh Spring Allergy Season Spurs Hay Fever Fears Harsh Spring Allergy Season Spurs Hay Fever Fears
A consistent increase in the intensity and length of allergy season in regions of the United States signals a difficult season in 2020, at the same time as the COVID-19 pandemic affects communities.Medscape Medical News
Source: Medscape Allergy Headlines - April 4, 2020 Category: Allergy & Immunology Tags: Allergy & Clinical Immunology News Source Type: news

Don ' t Endanger Your Patients: Stop Allergy Immunotherapy Now Don ' t Endanger Your Patients: Stop Allergy Immunotherapy Now
A medical society recently published recommendations to continue allergen immunotherapy during the COVID-19 pandemic. Is this the right decision?Medscape Allergy & Immunology
Source: Medscape Allergy Headlines - April 6, 2020 Category: Allergy & Immunology Tags: Allergy & Clinical Immunology Viewpoint Source Type: news

From Parkinson ' s to Peanut Allergy, Pandemic Puts Brakes on New Drugs From Parkinson ' s to Peanut Allergy, Pandemic Puts Brakes on New Drugs
Treatments for peanut allergy and Parkinson ' s disease are among U.S. drug launches that have been postponed by the COVID-19 pandemic as drugmakers struggle with disruptions to business, a Reuters review of filings and interviews with executives show.Reuters Health Information
Source: Medscape Allergy Headlines - July 2, 2020 Category: Allergy & Immunology Tags: Allergy & Clinical Immunology News Source Type: news

Primary Care Provider-Reported Prevalence of Vaccine and Polyethylene-Glycol Allergy in Canada
CONCLUSION: This is the first study to estimate the prevalence of vaccine and PEG allergy in a national cohort that utilizes PCP documentation, demonstrating a low reported rate of vaccine allergy and PEG allergy.PMID:34004274 | DOI:10.1016/j.anai.2021.05.011
Source: Annals of Allergy, Asthma and Immunology - May 18, 2021 Category: Allergy & Immunology Authors: Elissa M Abrams Matthew Greenhawt Marcus Shaker Leanne Kosowan Alexander G Singer Source Type: research

Change in Allergy Practice during the COVID-19 Pandemic
Conclusions: Allergists in Turkey have been using telemedicine at a high rate during the COVID-19 pandemic for asthma and rhinitis. The continuation rate of SCIT was low while the discontinuation rate of biologicals and systemic steroid use in asthma was high in Turkey.Our study results and learning from the experiences of other countries and specialties may help to optimize allergy practice and compatibility with international guidelines.Int Arch Allergy Immunol
Source: International Archives of Allergy and Immunology - October 15, 2020 Category: Allergy & Immunology Source Type: research

Assessment of current practice of paediatric respiratory and allergy teams in Cambridge University Hospital during the COVID-19 pandemic era and optimisation of the service
Introduction: The paediatric respiratory and allergy teams in Cambridge Hospital see patients with atopic and overlapping conditions, thus increasing travel for patients and hospital footfall. It is a tertiary reference hospital covering East England. Assessment of practice and changes of the service, in view of COVID-19 pandemic.Method: Retrospective assessment of patients: a) referred between the specialties (1/4/19- 31/3/20), investigations booked (lung function, skin prick testing, specific IgE, peak flow, inhaler and nasal spray technique) and patient flow. b) currently being seen by both teams (1/4/18-31/3/20).R...
Source: European Respiratory Journal - November 25, 2021 Category: Respiratory Medicine Authors: Powell, E., Nethercott, S., Ali, A., Wilson, G., Zolkipli, Z., Mcshane, D., Kotzia, D. Tags: Paediatric asthma and allergy Source Type: research

Paediatric allergy practice in the era of coronavirus disease 2019
Purpose of review To summarize the impact of the COVID-19 pandemic on the practice of paediatric allergy. Recent findings Given significant overlap in symptoms, care must be taken to differentiate routine allergic conditions from COVID-19 infection but it appears that most allergic diseases are not risk factors for a severe COVID-19 course. The full impact of restricted allergy/immunology ambulatory services will take months to years to fully understand. One benefit of having to adapt practice style is greater awareness and acceptance of shared decision-making and recognition of preference-sensitive care options...
Source: Current Opinion in Allergy and Clinical Immunology - March 3, 2021 Category: Allergy & Immunology Tags: PEDIATRIC ASTHMA AND DEVELOPMENT OF ATOPY: Edited by Andy Liu and Pasquale Comberiati Source Type: research

The Use and Teaching of Telemedicine in Allergy/Immunology Training Programs
AbstractPurpose of ReviewThe use of telemedicine has greatly increased since the onset of the coronavirus disease 2019 (COVID-19) pandemic. This review discusses the types of telemedicine, current telehealth curricula in medical education, and benefits and disadvantages of incorporation of telemedicine into Allergy/Immunology training programs.Recent FindingsThe majority of Allergists/Immunologists use telemedicine in their clinical practice with leaders in graduate medical education recommending inclusion of telemedicine in training. Fellows-in-training reported that use of telemedicine in Allergy/Immunology training duri...
Source: Current Allergy and Asthma Reports - July 7, 2023 Category: Allergy & Immunology Source Type: research

Online Education in Allergy and Immunology: An Update to Conferences Online in Allergy (COLA)
We describe here our long standing but unique approach to providing online education in the specialty of allergy and immunology and its impact.  Recent FindingsIn this article, we report the process and updates to our online conferencing curriculum known as Conferences Online in Allergy (COLA). The program was developed at Children ’s Mercy Kansas City almost two decades ago for the utilization of fellows in training, as well as practicing allergists. Since its inception viewership has continued to grow.SummaryCOLA has served as a significant resource for both the new and practicing allergists. With rapidly ...
Source: Current Allergy and Asthma Reports - May 25, 2023 Category: Allergy & Immunology Source Type: research

DAAB: A manually curated database of Allergy and Asthma Biomarkers
This article is protected by copyright. All rights reserved.
Source: Clinical and Experimental Allergy - May 1, 2015 Category: Allergy & Immunology Authors: Gaurab Sircar, Bodhisattwa Saha, Tanmoy Jana, Angira Dasgupta, Swati Gupta Bhattacharya, Sudipto Saha Tags: Letter to the editor Source Type: research

From the Pages of Allergy Watch
For this issue of From the Pages of Allergy Watch, I ’ve selected two articles related to COVID and asthma. The first reviewed by Dr Lee from the Nov-Dec Allergy Watch postulates that the ACE2 receptor may be protective in our allergic asthmatic patients and reduce the risk for hospitalization with COVID-19. The next article, reviewed by Dr Mahr, fr om the Sept-Oct Allergy Watch warns about stepping down controllers in pediatric asthma patients during the pandemic. The last article, reviewed by Dr Chipps, examines the role of eNO as a guide to ICS step-down decisions for our asthmatic patients.
Source: Annals of Allergy, Asthma and Immunology - January 12, 2021 Category: Allergy & Immunology Authors: Stanley M. Fineman, Gerald Lee, Todd Mahr, Bradley E. Chipps Tags: From the Pages of AllergyWatch Source Type: research

Emerging developments in the forefront of peanut oral immunotherapy
Purpose of review Despite the COVID-19 pandemic, progress continued in the field of peanut oral immunotherapy over the past 12 to 18 months. Of importance, the first oral immunotherapy product for the treatment of peanut allergy was approved by the US Food and Drug Administration in January 2020. Recent findings Suggested modifications to the practice of oral immunotherapy, some of which may have lasting impacts, were circulated as a result of the pandemic. New advances in pathophysiology, sustained unresponsiveness, quality of life, safety, and cost effectiveness were also published. Summary During 202...
Source: Current Opinion in Allergy and Clinical Immunology - April 30, 2021 Category: Allergy & Immunology Tags: FOOD ALLERGY: Edited by Alessandro Fiocchi and Motohiro Ebisawa Source Type: research